|
|
Blood, 15 February 2006, Vol. 107, No. 4, pp. 1405-1412.
Prepublished online as a Blood First Edition Paper on October 11, 2005; DOI 10.1182/blood-2005-06-2406.
Previous Article | Next Article 
Submitted June 21, 2005
Accepted October 1, 2005
Laminin stimulates spreading of platelets through integrin 6 1-dependent activation of GPVI
Osamu Inoue*, Katsue Suzuki-Inoue, Owen J McCarty, Masaaki Moroi, Zaverio M Ruggeri, Thomas J Kunicki, Yukio Ozaki, and Steve P Watson
Department of Clinical and Laboratory Medicine, University of Yamanashi, Nakakoma, Yamanashi, Japan
Centre for Cardiovascular Sciences, Institute of Biomedical Research, University of Birmingham, Birmingham, United Kingdom
Department of Protein Biochemistry, Institute of Life Science, Kurume University, Kurume, Fukuoka, Japan
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
* Corresponding author; email: oinoue{at}yamanashi.ac.jp.
The extracellular matrix protein, laminin, supports platelet adhesion through binding to integrin 6 1. In the present study, we demonstrate that human laminin, purified from placenta, also stimulates formation of filopodia and lamellipodia in human and mouse platelets through a pathway that is dependent on 6 1 and the collagen receptor GPVI. The integrin 6 1 is essential for adhesion to laminin, as demonstrated using an 6-blocking antibody, whereas GPVI is dispensable for this response, as shown using 'knockout' mouse platelets. On the other hand, lamellipodia formation on laminin is completely inhibited in the absence of GPVI, although filopodia formation remains and is presumably mediated via 6 1. Lamellipodia and filopodia formation are inhibited in Syk-deficient platelets, demonstrating a key role for the kinase in signaling downstream of GPVI and integrin 6 1. GPVI was confirmed as a receptor for laminin using surface plasmon resonance spectroscopy and by demonstration of lamellipodia formation on laminin in the presence of collagenase. These results identify GPVI as a novel receptor for laminin and support a model in which integrin 6 1 brings laminin to GPVI, that in turn mediates lamellipodia formation. We speculate that laminin contributes to platelet spreading in vivo through a direct interaction with GPVI.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
New role for the GPVI/FcR
chain complex
- Peter J. Newman
Blood 2006 107: 1248-1249.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
M. Prokopi, G. Pula, U. Mayr, C. Devue, J. Gallagher, Q. Xiao, C. M. Boulanger, N. Westwood, C. Urbich, J. Willeit, et al.
Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures
Blood,
July 16, 2009;
114(3):
723 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Boylan, C. Gao, V. Rathore, J. C. Gill, D. K. Newman, and P. J. Newman
Identification of Fc{gamma}RIIa as the ITAM-bearing receptor mediating {alpha}IIb{beta}3 outside-in integrin signaling in human platelets
Blood,
October 1, 2008;
112(7):
2780 - 2786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Inoue, K. Suzuki-Inoue, and Y. Ozaki
Redundant Mechanism of Platelet Adhesion to Laminin and Collagen under Flow: INVOLVEMENT OF VON WILLEBRAND FACTOR AND GLYCOPROTEIN Ib-IX-V
J. Biol. Chem.,
June 13, 2008;
283(24):
16279 - 16282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Varga-Szabo, I. Pleines, and B. Nieswandt
Cell Adhesion Mechanisms in Platelets
Arterioscler Thromb Vasc Biol,
March 1, 2008;
28(3):
403 - 412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Andrews, D. Karunakaran, E. E. Gardiner, and M. C. Berndt
Platelet Receptor Proteolysis: A Mechanism for Downregulating Platelet Reactivity
Arterioscler Thromb Vasc Biol,
July 1, 2007;
27(7):
1511 - 1520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. M. Ruggeri and G. L. Mendolicchio
Adhesion Mechanisms in Platelet Function
Circ. Res.,
June 22, 2007;
100(12):
1673 - 1685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Boylan, M. C. Berndt, M. L. Kahn, and P. J. Newman
Activation-independent, antibody-mediated removal of GPVI from circulating human platelets: development of a novel NOD/SCID mouse model to evaluate the in vivo effectiveness of anti-human platelet agents
Blood,
August 1, 2006;
108(3):
908 - 914.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|